GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JCR Pharmaceuticals Co Ltd (TSE:4552) » Definitions » Price-to-Funds-From-Operations

JCR Pharmaceuticals Co (TSE:4552) Price-to-Funds-From-Operations : (As of Jun. 01, 2024)


View and export this data going back to 2011. Start your Free Trial

What is JCR Pharmaceuticals Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


JCR Pharmaceuticals Co (TSE:4552) Business Description

Traded in Other Exchanges
Address
3-19 Kasuga-cho, Ashiya, Hyogo, JPN, 659-0021
JCR Pharmaceuticals Co Ltd is a major drug manufacturing company proactively engaged in the research of enzymes and proteins. The company maintains a focus toward developing value-added treatment options to address unmet medical needs. JCR utilizes international partnerships as a component of its growth strategy. The vast majority of JCR's revenue is generated from its pharmaceutical operations, followed by medical devices and laboratory equipment. A portion of the company's sales are derived from licensing agreements.